Early drug safety trial halted after testing on healthy volunteers

NCT ID NCT03809039

Summary

This was an early-stage study to check the safety and see how the body processes a new, unnamed drug called MT-6345. It involved 52 healthy volunteers who received either the drug or a placebo. The main goal was to see what side effects occurred and to measure how the drug moved through and was eliminated from the body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational center

    City Name, United Kingdom

Conditions

Explore the condition pages connected to this study.